isophosphamide mustard has been researched along with Bone Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Canitrot, D; Chezal, JM; Galmier, MJ; Gaumet, V; Gerard, Y; Ghedira, D; Maubert, E; Miot-Noirault, E; Peyrode, C; Tarrit, S; Voissière, A; Weber, V | 1 |
1 other study(ies) available for isophosphamide mustard and Bone Neoplasms
Article | Year |
---|---|
Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chondrosarcoma; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms, Connective and Soft Tissue; Phosphoramide Mustards; Prodrugs; Structure-Activity Relationship | 2020 |